Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-024446
Filing Date
2018-09-13
Accepted
2018-09-13 17:25:26
Documents
1
Period of Report
2018-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7127
  Complete submission text file 0000899243-18-024446.txt   8437
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 101 HARTWELL AVE. LEXINGTON MA 02421
Business Address
Barclay Alec (Reporting) CIK: 0001734339 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36571 | Film No.: 181069570